Spanish Authorities Investigate Sandoz Over Information-Sharing

CNMC Regulator Announces Probe Into Sandoz, Bexal, Bluetab And Alliance

Spanish competition regulator the CNMC has announced an investigation into Sandoz and its Bexal subsidiary – as well as Alliance Healthcare España and Bluetab Solutions – over sharing sensitive commercial information relating to pharmacy orders for generics.

The CNMC has announced an investigation over the sharing of sensitive information (Shutterstock)

Spain’s competition authority, the CNMC, has announced that it is investigating Sandoz and its Bexal subsidiary – as well as other companies Alliance Healthcare España and Bluetab Solutions – over the exchange of sensitive commercial information relating to orders placed by pharmacies for Sandoz/Bexal generics.

The CNMC said that the alleged exchange of “sensitive, unjustified and disaggregated commercial information” took place from April 2018 to April 2023

More from Legal & IP

More from Products